3 Oil ETFs to Buy as Crude Prices Rise Again
Oil prices have rebounded nicely from historic lows. As energy stocks rise, these three oil ETFs are an efficient way to play the rally.
Read More
oil prices Archives
Cabot Early Opportunities Special Bulletin
This morning we found out that Endava (DAVA) has postponed its Q4 earnings report from tomorrow (September 23) until next Tuesday (September 28).
Read More
Cabot Undervalued Stocks Advisor Weekly Update
It’s not news that the stock market has been sloppy lately. After the steady march upward to a doubling of the S&P 500 from the early 2020 low, and a 33% increase from year-end 2019 before the pandemic, one can hardly be disappointed the...
Read More
Cabot Income Advisor 921
The market had the worst day in months Monday on news that Chinese real estate giant Evergrande may default on $300 billion in debt. There is fear that such an event could cause contagion and ripple through the financial markets.
Read More
Cabot Micro-Cap Insider Update
This week, everyone is talking about Evergrande. In case you’ve missed it, Evergrande is a Chinese real estate developer. Its core business is building homes, but it branched out into other directions like investing in EVs, a theme park, and other business lines.
Read More
Cabot Profit Booster 193
The one trade from the September expiration cycle that was not closed last week was CFX, which leaves us with the stock and no option position. While it is possible that CFX will rebound in the days/weeks to come, because of the market weakness, am...
Read More
Cabot Stock of the Week 366
The long bull market continues, despite this morning’s sharp selloff, and thus I continue to recommend that you be heavily invested in a portfolio that meets your investment needs.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
After a stunningly strong market so far this year, with the S&P 500 producing a 20% total return through Monday, the slow grind-down of most stocks since early September has seemed interminable. The 1,100 largest stocks in our 3,000-stock database have declined only in...
Read More
Cabot Turnaround Letter Weekly Update
Today’s note includes the podcast.
Read More
Cabot Early Opportunities Special Bulletin
Today we’re stepping away from our remaining three-quarter position in long-term holding 10X Genomics (TXG), which we added in December 2019. The stock has been moving sideways since January, and this week management spoke at conferences and suggested it is seeing lower-than-expected lab during...
Read More
Cabot Growth Investor Bi-weekly Update
The action in the second half of August was encouraging, but as has been the story of 2021, a lot of that move has been erased so far in September—and that goes for just about everything.
Read More
Cabot Explorer 744
With more than 10,000 baby boomers reaching 65 each day in America, you can bet that medical services aimed at this giant group are growth markets.
Read More
Cabot Small-Cap Confidential Weekly Update
The S&P 500 has finally failed to make a new high every day lately and is 2% below the high-water mark! That doesn’t seem like it should be news but in this market it’s worth noting.
Read More
Cabot Dividend Investor Weekly Update
So far, the post-Labor Day market has been just a little bit crummy. Stocks have drifted slightly lower over the past week. While that’s nothing alarming, it is a reversal of the summer market where stocks were drifting slightly higher. It could be the...
Read More
Cabot Income Advisor Weekly Update
Here we are in September. So far, it’s not bad. But it’s not good either. For the first week after Labor Day, the market has drifted lower. It’s no big deal. But stocks have been losing a battle they were winning in the The...
Read More
Cabot Micro-Cap Insider Update
The market seems expensive, but the S&P 500 keeps making new all-time highs.
Read More
Cabot Early Opportunities 125
Stock Name
Market Cap
Price
Investment Type
Asana (ASAN) *
$19.4 billion
106.5
Rapid Growth – Software
Bellring Brands (BRBR)
$1.25 billion
31.07
Growth – Consumer
Dlocal Limited (DLO)
$18.5 billion
64.07
Rapid Growth – Payments
Snowflake (SNOW)
$94.3
319.25
Rapid Growth – Software
Travere Therapeutics (TVTX)
$1.45 billion
23.61
Development Stage – Biotech
*Watch List Addition
Growth is Where it’s at
First off, I want to thank everyone responded...
Read More
Cabot Prime Pro Week Ending September 17, 2021
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Prime Week Ending September 17, 2021
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Cabot Profit Booster 192
Last week all the major indices took a small step back. The S&P 500 lost 1.69%, the Dow fell 2.15%, and the Nasdaq declined 1.61%.
The headlines say the 5-day pullback was the largest for the S&P 500 since February. But considering that the of...
Read More